<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04225507</url>
  </required_header>
  <id_info>
    <org_study_id>IRB19-1445</org_study_id>
    <secondary_id>R01DK120312</secondary_id>
    <nct_id>NCT04225507</nct_id>
  </id_info>
  <brief_title>Technology-Supported Treatment of Sleep Apnea in Prediabetes</brief_title>
  <acronym>TECH</acronym>
  <official_title>Technology-Supported Treatment of Sleep Apnea in Prediabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the efficacy of intensive lifestyle interventions in prediabetes, the incidence of&#xD;
      diabetes is rising, and thus there is a critical need for additional strategies to prevent&#xD;
      diabetes and to reduce its cardiovascular complications in this high-risk population. Sleep&#xD;
      apnea is a highly common condition in prediabetes, but it has been mostly ignored and&#xD;
      undertreated in current practice. The proposed study will be the first to assess whether&#xD;
      adding CPAP (continuous positive air pressure) treatment to a lifestyle intervention improves&#xD;
      cardiometabolic outcomes beyond that achieved with lifestyle alone (i.e. current standard of&#xD;
      care) in high-risk individuals with prediabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 6-month randomized controlled, parallel group trial with two arms. After baseline,&#xD;
      the subjects will be randomized to lifestyle intervention alone (lifestyle group) or&#xD;
      lifestyle plus CPAP intervention (lifestyle plus CPAP group). The same metabolic and&#xD;
      cardiovascular assessments will be performed at baseline and after 6-months of intervention.&#xD;
&#xD;
      The lifestyle group will aim to achieve a weight loss through diet and exercise. The&#xD;
      lifestyle plus CPAP group will additionally receive CPAP treatment. All subjects will use a&#xD;
      custom smartphone app to track weight loss and/or CPAP goals and will receive weekly coaching&#xD;
      phone calls to maximize treatment adherence.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 13, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline 2-hour glucose levels at 6 months</measure>
    <time_frame>Baseline and at 6 months</time_frame>
    <description>Glucose levels will be measured at time=120min during oral glucose tolerance test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline morning blood pressure at 6 months</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Morning blood pressure will be measured with a blood pressure cuff while sitting</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline fasting glucose levels at 6 months</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Fasting blood glucose levels will be measured in the morning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline 24-hour blood pressure at 6 months</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>24-hour blood pressure will be measured using and ambulatory blood pressure device</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">740</enrollment>
  <condition>Sleep Apnea</condition>
  <condition>PreDiabetes</condition>
  <condition>Overweight or Obesity</condition>
  <arm_group>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Diet and exercise.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lifestyle Plus CPAP Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CPAP treatment, diet and exercise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diet and exercise coaching</intervention_name>
    <description>All participants will receive diet and exercise goals and coaching.</description>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
    <arm_group_label>Lifestyle Plus CPAP Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CPAP Treatment</intervention_name>
    <description>CPAP treatment for sleep apnea and CPAP education and adherence coaching.</description>
    <arm_group_label>Lifestyle Plus CPAP Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Overweight or obese&#xD;
&#xD;
          -  Prediabetes&#xD;
&#xD;
          -  Sleep apnea&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetic&#xD;
&#xD;
          -  enrolled in a formal weight loss program&#xD;
&#xD;
          -  Any underlying disease likely to limit life span and/or increase risk of interventions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esra Tasali, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Millie Maleckar</last_name>
      <phone>773-702-6505</phone>
      <email>mmalecka@bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Esra Tasali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 7, 2020</study_first_submitted>
  <study_first_submitted_qc>January 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2020</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

